ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 77 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $34,000 | -40.4% | 26,444 | -19.4% | 0.00% | – |
| Q4 2021 | $57,000 | -18.6% | 32,802 | +2.2% | 0.00% | – |
| Q3 2021 | $70,000 | -50.0% | 32,094 | -20.0% | 0.00% | – |
| Q2 2021 | $140,000 | -62.0% | 40,133 | +7.7% | 0.00% | -100.0% |
| Q1 2021 | $368,000 | -2.4% | 37,276 | +7.2% | 0.00% | 0.0% |
| Q4 2020 | $377,000 | +40.7% | 34,757 | +33.8% | 0.00% | 0.0% |
| Q3 2020 | $268,000 | -43.6% | 25,973 | +14.1% | 0.00% | -66.7% |
| Q2 2020 | $475,000 | +289.3% | 22,755 | +82.1% | 0.00% | +200.0% |
| Q1 2020 | $122,000 | -50.2% | 12,499 | -41.3% | 0.00% | 0.0% |
| Q4 2019 | $245,000 | +89.9% | 21,284 | -9.8% | 0.00% | 0.0% |
| Q3 2019 | $129,000 | -55.4% | 23,600 | -2.8% | 0.00% | -50.0% |
| Q2 2019 | $289,000 | +102.1% | 24,280 | -11.0% | 0.00% | +100.0% |
| Q1 2019 | $143,000 | +68.2% | 27,276 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $85,000 | -26.7% | 27,046 | -4.6% | 0.00% | -50.0% |
| Q3 2016 | $116,000 | +9.4% | 28,344 | -15.4% | 0.00% | +100.0% |
| Q2 2016 | $106,000 | – | 33,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 420,000 | $1,134,000 | 0.67% |
| EcoR1 Capital, LLC | 874,447 | $2,361,000 | 0.60% |
| VHCP Management II, LLC | 280,000 | $756,000 | 0.31% |
| 683 Capital Management, LLC | 350,000 | $945,000 | 0.15% |
| AWM Investment Company, Inc. | 400,000 | $1,080,000 | 0.10% |
| JW Asset Management, LLC | 178,654 | $482,000 | 0.10% |
| TFS CAPITAL LLC | 89,156 | $241,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 154,006 | $416,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 282,630 | $763,000 | 0.04% |
| Numeric Investors LLC | 1,087,967 | $2,938,000 | 0.03% |